40 results on '"Gu, Yushen"'
Search Results
2. Total-body dynamic PET/CT imaging reveals kinetic distribution of [13N]NH3 in normal organs
3. Recommended Workflow of Total-Body PET/CT Application in Clinical
4. Comparison of 18F-FDG PET/MR and PET/CT for pretreatment TNM staging of hilar cholangiocarcinoma
5. An exploration of the feasibility and clinical value of half-dose 5-h total-body 18F-FDG PET/CT scan in patients with Takayasu arteritis
6. Expert consensus on oncological [18F]FDG total-body PET/CT imaging (version 1)
7. Optimizing acquisition times for total-body positron emission tomography/computed tomography with half-dose 18F-fluorodeoxyglucose in oncology patients
8. NEMA NU2-2012 performance measurements of the United Imaging uPMR790: an integrated PET/MR system
9. Performance characteristics of the digital uMI550 PET/CT system according to the NEMA NU2-2018 standard
10. Volumetric parameters on 18F-FDG PET/CT predict the survival of patients with gastric cancer associated with their expression status of c-MET
11. Berberine promotes the recruitment and activation of brown adipose tissue in mice and humans
12. Comparison of 18F-FDG PET/MR and PET/CT for pretreatment TNM staging of hilar cholangiocarcinoma.
13. An exploration of the feasibility and clinical value of half-dose 5-h total-body 18F-FDG PET/CT scan in patients with Takayasu arteritis.
14. Expert consensus on oncological [18F]FDG total-body PET/CT imaging (version 1)
15. Optimizing acquisition times for total-body positron-emission tomography/computed tomography with half-dose 18F-fluorodeoxyglucose in oncology patients
16. Additional file 2 of Optimizing acquisition times for total-body positron emission tomography/computed tomography with half-dose 18F-fluorodeoxyglucose in oncology patients
17. Additional file 1 of Optimizing acquisition times for total-body positron emission tomography/computed tomography with half-dose 18F-fluorodeoxyglucose in oncology patients
18. Optimizing Acquisition Times for Total-Body Positron-Emission Tomography/Computed Tomography with Half-Dose 18F-Fluorodeoxyglucose in Oncology Patients
19. Design and preliminary assessment of 99mTc-labeled ultrasmall superparamagnetic iron oxide-conjugated bevacizumab for single photon emission computed tomography/magnetic resonance imaging of hepatocellular carcinoma
20. Expert consensus on oncological [18F]FDG total-body PET/CT imaging (version 1).
21. Diagnostic value of 99mTc-MDP SPECT/spiral CT combined with three-phase bone scintigraphy in assessing suspected bone tumors in patients with no malignant history
22. Optimizing acquisition times for total-body positron emission tomography/computed tomography with half-dose 18F-fluorodeoxyglucose in oncology patients.
23. Evaluation of SNA001, a Novel Recombinant Human Thyroid Stimulating Hormone Injection, in Patients With Differentiated Thyroid Carcinoma
24. Added value of SPECT/spiral CT versus SPECT in diagnosing solitary spinal lesions in patients with extraskeletal malignancies
25. Differential diagnostic value of single-photon emission computed tomography/spiral computed tomography with Tc-99m-methylene diphosphonate in patients with spinal lesions
26. Validation of MR-Based Attenuation Correction of a Newly Released Whole-Body Simultaneous PET/MR System
27. Does the ISA Really Matter? A Simulation Based Investigation
28. Added value of SPECT/spiral CT versus SPECT or CT alone in diagnosing solitary skeletal lesions
29. Design and preliminary assessment of 99mTc-labeled ultrasmall superparamagnetic iron oxide-conjugated bevacizumab for single photon emission computed tomography/magnetic resonance imaging of hepatocellular carcinoma
30. Added value of SPECT/spiral CT versus SPECT or CT alone in diagnosing solitary skeletal lesions
31. Primary Pulmonary Osteosarcoma
32. Design and preliminary assessment of Tc-labeled ultrasmall superparamagnetic iron oxide-conjugated bevacizumab for single photon emission computed tomography/magnetic resonance imaging of hepatocellular carcinoma.
33. Volumetric parameters on 18F-FDG PET/CT predict the survival of patients with gastric cancer associated with their expression status of c-MET.
34. Total-body dynamic PET/CT imaging reveals kinetic distribution of [13N]NH3 in normal organs.
35. Technetium-99m-pertechnetate whole-body SPET/CT scan in thyroidectomized differentiated thyroid cancer patients is a useful imaging modality in detecting remnant thyroid tissue, nodal and distant metastases before 131 I therapy. A study of 416 patients.
36. Sarcomatoid carcinoma of the lung mimics aspergilloma on ¹⁸F-FDG PET/CT.
37. Optimized image acquisition parameters for imaging radioactive iodine-125 seed implantation for cancer treatment.
38. Evaluation of the therapeutic response by (99m)Tc-ECD-SPET in a female with non-organic depression, generalized anxiety and heterophobia.
39. Micro-SPET/CT and histology results of zoledronate treatment in a nude mouse lung adenocarcinoma skeletal metastases model: a pilot study.
40. Primary pulmonary osteosarcoma: PET/CT and SPECT/CT findings.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.